At CureSearch, we are excited to announce our funding portfolio for 2013! Over the last 25 years, CureSearch has been a leader in funding children’s cancer research and this year we are launching a new funding platform that will help accelerate the search for cures.
CureSearch will to continue to support clinical trials through the Clinical Trial Advancement Awards, a program that distributes funds to hospitals in the United States enrolling patients in Phase I, Phase II, and Phase III therapeutic clinical trials. At CureSearch we believe that clinical trials are the key to making a difference for children with cancer, today.
Not only will we continue to support clinical trials and provide educational resources, we will for the first time invest significant dollars into preclinical and clinical research aimed at accelerating the cure for children at the greatest risk of losing their battle with cancer.